Blood pressure and metabolic effects of nebivolol compared with hydrochlorothiazide and placebo in hypertensive patients with impaired glucose tolerance or impaired fasting glucose
Phase of Trial: Phase IV
Latest Information Update: 24 May 2011
At a glance
- Drugs Nebivolol (Primary) ; Hydrochlorothiazide; Lisinopril; Losartan
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors Forest Laboratories
- 24 May 2011 Results presented at the 26th Annual Scientific Meeting of the American Society of Hypertension.
- 22 Sep 2010 Actual end date added to 1 Jul 2010 as reported by ClinicalTrials.gov.
- 22 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History